| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1092092358 |
| P356 | DOI | 10.1038/S41598-017-12885-4 |
| P932 | PMC publication ID | 5635123 |
| P698 | PubMed publication ID | 29018269 |
| P50 | author | María Ángeles Jiménez-Sousa | Q57419382 |
| Luz María Medrano | Q59679472 | ||
| Francisco Leonardo Tejerina-Garro | Q89602785 | ||
| Amanda Fernández-Rodríguez | Q91979545 | ||
| Lorena Vigón | Q92982972 | ||
| Teresa Aldámiz-Echevarria | Q114441443 | ||
| Salvador Resino | Q40087991 | ||
| Juan Berenguer | Q47548434 | ||
| P2093 | author name string | Cristina Diez | |
| P2860 | cites work | An integrative scoring system for ranking SNPs by their potential deleterious effects | Q83379209 |
| Polymorphisms in ADAR1 gene affect response to interferon alpha based therapy for chronic hepatitis B in Han Chinese | Q83746882 | ||
| RNA editing catalyzed by ADAR1 and its function in mammalian cells | Q37948851 | ||
| Coinfection by human immunodeficiency virus and hepatitis C virus: noninvasive assessment and staging of fibrosis | Q38022504 | ||
| False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies | Q38211946 | ||
| News on HIV-HCV Coinfection: Update From the 2015 GEHEP Conference | Q38652490 | ||
| The ADAR1 editing enzyme is encapsidated into HIV-1 virions | Q38835854 | ||
| Immune responses and immunopathology in acute and chronic viral hepatitis | Q38885002 | ||
| Mesenchymal-stem-cell-derived exosomes accelerate skeletal muscle regeneration | Q38888737 | ||
| Genetic Polymorphisms Associated with Liver Disease Progression in HIV/HCV-Coinfected Patients | Q39128402 | ||
| Statement on outpatient percutaneous liver biopsy | Q39475420 | ||
| Improving microRNA target prediction by modeling with unambiguously identified microRNA-target pairs from CLIP-ligation studies | Q40130973 | ||
| RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase | Q41206734 | ||
| Impact of common risk factors of fibrosis progression in chronic hepatitis C. | Q41741892 | ||
| ADAR1 Prevents Liver Injury from Inflammation and Suppresses Interferon Production in Hepatocytes | Q41760086 | ||
| Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus. | Q42990078 | ||
| Peginterferon alfa-2a plus ribavirin is more effective than peginterferon alfa-2b plus ribavirin for treating chronic hepatitis C virus infection | Q42992027 | ||
| The natural history of liver cirrhosis in HIV-hepatitis C virus-coinfected patients | Q43034421 | ||
| Recommendations of Gesida/PNS/AEEH for the management and treatment of the adult patient co-infected with HIV and hepatitis A, B and C virus | Q43179912 | ||
| IL28RA polymorphism is associated with early hepatitis C virus (HCV) treatment failure in human immunodeficiency virus-/HCV-coinfected patients. | Q43845101 | ||
| An artificial neural network improves the non-invasive diagnosis of significant fibrosis in HIV/HCV coinfected patients. | Q43946257 | ||
| Interferon-stimulated gene expression in black and white hepatitis C patients during peginterferon alfa-2a combination therapy | Q44286199 | ||
| A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. | Q44527614 | ||
| Expression of interferon-inducible RNA adenosine deaminase ADAR1 during pathogen infection and mouse embryo development involves tissue-selective promoter utilization and alternative splicing | Q45242048 | ||
| Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment | Q45733180 | ||
| Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 | Q21534928 | ||
| New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1 | Q24300907 | ||
| ADAR1 forms a complex with Dicer to promote microRNA processing and RNA-induced gene silencing | Q24339141 | ||
| A global reference for human genetic variation | Q25909434 | ||
| Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 | ||
| Adenosine-to-inosine RNA editing and human disease | Q26853110 | ||
| Natural history of hepatitis C | Q27000737 | ||
| Using high-throughput genomics to study hepatitis C: What determines the outcome of infection? | Q27488407 | ||
| Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral | Q28302608 | ||
| Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection | Q29417113 | ||
| Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups | Q29614459 | ||
| An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group | Q29614898 | ||
| Ensembl 2015 | Q29615570 | ||
| Diagnosis, management, and treatment of hepatitis C: an update | Q29619682 | ||
| Hepatitis C virus infection | Q30235491 | ||
| ADAR1 deletion induces NFκB and interferon signaling dependent liver inflammation and fibrosis | Q33739718 | ||
| Interferon-stimulated genes: a complex web of host defenses | Q34405609 | ||
| Relationship between differential hepatic microRNA expression and decreased hepatic cytochrome P450 3A activity in cirrhosis | Q34994708 | ||
| The dsRNA binding protein family: critical roles, diverse cellular functions | Q35139546 | ||
| miRDB: an online resource for microRNA target prediction and functional annotations | Q35253629 | ||
| ADAR1 Facilitates HIV-1 Replication in Primary CD4+ T Cells | Q35858559 | ||
| Impact of polymorphisms in microRNA biogenesis genes on colon cancer risk and microRNA expression levels: a population-based, case-control study | Q35997432 | ||
| Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection | Q36339002 | ||
| Sample size and statistical power calculation in genetic association studies. | Q36345804 | ||
| Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial | Q37217280 | ||
| The prevalence and risk factors for abnormal liver enzymes in HIV-positive patients without hepatitis B or C coinfections | Q37332151 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 12918 | |
| P577 | publication date | 2017-10-10 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | ADAR1 polymorphisms are related to severity of liver fibrosis in HIV/HCV-coinfected patients | |
| P478 | volume | 7 |
Search more.